1 What is Arthritis? There are 127 different k i nds of arthritis! Rheumatoid arthritis : Severe inflammation that involves many joints and moves beyond musculoskeletal system. Gout : Very painful form of arthritis characterized by the formation of uric acid crystals and severe inflammation. Osteoarthritis : progressive degeneration of joint cartilage. Minor degree of inflammation.
GOUT
Gout is a metabolic disorder of purine metabolism, characterized by intermittent attacks of acute pain, swelling and inflammation. It always preceded by hyperuricaemia
Hyper uricaemia 6.8mg/dl E xcessive amount of uric acid production Decreased excretion Or both
Primary Hyperuricemia and Gout Uricacid under excretion 80–90% Urate over production (10–20 %) Purine intake shell fish , Red meat Idiopathic PRPP synthetase over activity Secondary Hyperuricemia and Gout Identifiable Associated Condition develop during course of other diseases (lymphomas , chemotherapy, CKD) cell death Some drug therapy (Thiazide diuretics, furosamide , ethacrynic acid, Aspirin) Some disorders Diabetic ketoacidosis , lead poison, Lymphoproliferative diseases , Hemolytic anemias , psoriasis Dual mechanism Obesity and hypo perfusion to joint
Uric acid production and excretion RNA,DNA PURINES HYPOXANTHINES XANTHINES URIC ACID (low water soluble) Uric acid freely filtrated through by glomerulus and reabsorbed by tubular fluid Xanthine oxidase Xanthine oxidase Probencid PRPP Hyperuricemia Gout Deposits of urate crystal
Pathophysiology of gout Uricacid Blood React with sodium Sodium crystals ( tophi ) Deposited in soft tissues and joints Inflammation( ry ) Infiltration of granulocytes that phagocytise the urate crystals Generate free radicals Free radical damage the tissue Release of proteolytic enzyme glycoprotein Release of lactic acid More ppt of urate crystals Indomethacin Colchicine Colchicine Colchicine Release of lysosomal enzymes Destruction of joints
Symptoms Acute joint pain Swelling in the joints Skin may be in red colour and shiny appearance Formation of tyophi
Cause and risk factors Hereditary factors 40-50 age Consumption of alcohol spe ..Beer Excessive consumption of red meat, internal organs Trauma to joints
Acute gout Painful arthritic attack of sudden onset. Usually occurring at night or in early morning Arthritic pain worsen progressively Generally involves one or few joints Most common site of initial attack metatarsophalangeal joint. Other sites ankle, heel, knee, wrist, elbow and fingers.
Chronic gout Frequency of attacks increases, continuous deposit leads to damage joints and chronic pain Patients may develop large subacutenous tophi (Stones) in pinna of external ear, eyelids, nose and around joints The ureate crystals in kidney leads renal disease. Articular cartilage may be destroyed result in joint deformities
Colchicine Alkaloid from colchium autumnale . (1973) Neither analgesic nor anti inflammatory, but specific for gouty inflammation. It is only effective in prophylaxis of acute gout It has no effect on synthesis or promote excretion MOA Colchicine binds to intracellular protein ‘ Tubulin ’ and causes depolymerisation and disappearance of microtubules in granulocytes & Inhibit granulocyte migration so dec phagocytic activity
Colchicine inhibit glycoprotein release Other actions- - arrest of mitosis in metaphase “spindle poison” - increases gut motility. - Antipyretic , respiratory depressant - Inhibit histamine , Insulin release - hypertensive at high dose, Increase vasomotor tone
Uses Colchicine preferred in pts without confirmed diagnosis of gout. Acute gout-1mg orally followed by 0.25 mg 3 hrly till control. EHC 3-7days With safer alternatives NSAIDs use of Colchicine have declined ADR :- diarrhoea, vomiting, abdominal pain. Acute toxicity - bloody diarrhoea, throat pain, respiratory depression, haematuria . Chornic toxicity- agranulocytosis, peripheral neuritis and myopathy , renal tubular necrosis.
NSAIDs Strong anti inflammatory drugs Use in patients without contraindication Use maximum dose/potent NSAID e.g., Indomethacin 50 mg po t.i.d . Diclofenac 50 mg po t.i.d . Ketorolac 10 mg q4-6hrsr, Napoxen , Piroxicam continue until pain/inflammation absent for 48 hours MOA : inhibit urate crystal phagocytosis and chemotatic migration of leukocytes into inflammed joints. NSAIDs are not recommended for long term. ( Salicylates are not used , have tendency to raise uric acid)
Corticosteroid Use when NSAIDS/ Cholchicine risky or contraindicated e.g.,: elderly hypertensive peptic ulcer disease renal impairment liver impairment use when • NSAIDS ineffective Mode of administration – intra articular - Depomedrol 40-80 mg with lidocaine . Oral Prednisone 30-40 mg qd for 3-4 days, taper by 5 mg every 2-3 days & stop over 1-2 wks
Allopurinol prevents the synthesis of uric acid by inhibiting the enzyme Xanthine oxidase, result reduce plasma ureate levels. Inc. xanthine, hypoxanthines are excreted through urine Allopurinol short acting competitive inhibitor Metabolite alloxanthine is long acting t 1/2 24hr.
Start low 50-100 mg qd Increase by 50-100mg every 2-3 weeks according to symptoms “Average” dose 300 mg daily – lower dose if renal/hepatic insufficiency – higher dose in non-responders prophylactic colchicine until allopurinol dose stable Indications : Chronic gout In patients 24 hrs urinary acid excretion exceeds 1.1g For recurrent renal ureate stones.
Allopurinol side effects GI upset, alopecia, cataract. Allopurinol Hypersensitivity: Pruritic papular skin rash, fever, hepatitis, eosinophilia , renal impairment CI:- Chidrens Elderly patients Pregnancy Lactation Liver and kidney diseases.
Allopurinol drug interactions Allopurinol prolong ½ life of Vidarabine , Cyclosporin drugs and increase toxicity Dec. metabolism of 6-mercaptopurine, Azothiaprine inc. its effects. Interferes with the mobilization of hepatic iron stores - heamtonic should be avoided during allopurinol therapy.
Uricosuric drugs: (probencid) Highly lipid soluble benzoic acid. It blocks reabsorption of urate in proximal tubule by blocking transport ( Bidirectional transport ) PK: Dose dependent t1/2 life Dose -250- 500mg b.d . with plenty of fluids, alkalinization of urine . Uses : chronic gout along with NSAIDs / colchicine for initial 1-2 months.
Sulfinpyrazone It is a Pyrazolone derivaties related to Phenylbutazone . Inhibits tubular reabsorption of uric acid at therapeutic doses. Its action is additive with probenecid . Use -chronic gout Dose :100-200mg BD gradually increase according to the response.
It is newer and more potent uricosuric drug Used in patients allergic to probenecid or sulfinpyrazone It is reversible inhibitor of tubuler reabsorption Effective dose 60-80mg/day With allopurinol more effective Benzbromarone
A 56yrs old male awake in the night with sudden severe pain in his first metatarsophalangeal joint which lasted for a week. Over the next few months, he had similar acute episode of pain in his ankles and knees, as well as his big toe. The GP suspected gout and referred him to specialist What treatment should be GP institute for the acute attacks prior to the specialist diagnosis?
what test could the rheumatologist do to confirm the suspected diagnosis? What is the cause of gout? Which drugs act for acute attacks? What would you prescribe for prophylaxis to reduce recurrent attacks ?